Infinity Lithium Corporation Limited (INF.AX)
AUD 0.02
(-4.0%)
AUD 0.02
(-4.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | 172 Thousand | - | - | - | - |
| Cost of Revenue | 6000.00 | 5000.00 | 3000.00 | 263.00 | - | 118.00 |
| Gross Profit | -6000.00 | 167 Thousand | -3000.00 | -263.00 | - | -118.00 |
| Operating Expenses | 4.28 Million | 4.06 Million | 6.19 Million | 2.69 Million | 1.8 Million | 2.77 Million |
| Selling, General and Administrative Expenses | 4.28 Million | 4.06 Million | 6.19 Million | 2.69 Million | 1.8 Million | 1.45 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | 262 Thousand | 134 Thousand | 5.15 Million | 153.66 Thousand | 365.55 Thousand |
| Cost and Expenses | 4.28 Million | 4.06 Million | 6.19 Million | 2.69 Million | 1.8 Million | 2.77 Million |
| Operating Income | -4.28 Million | -4.06 Million | -6.19 Million | -2.69 Million | -1.8 Million | -2.11 Million |
| Interest Expense | - | - | - | 505.00 | - | - |
| Income Tax Expense | - | 319 Thousand | 223 Thousand | -3.00 | -118.00 | -7136.00 |
| Earnings before Tax | -3.67 Million | -3.63 Million | -6.06 Million | 2.45 Million | -1.65 Million | -2.72 Million |
| Net Income | -3.67 Million | -3.95 Million | -6.28 Million | 2.45 Million | -1.65 Million | -2.72 Million |
| Earnings Per Share Basic | -0.01 | -0.01 | -0.02 | 0.01 | -0.01 | -0.01 |
| Earnings Per Share Diluted | -0.01 | -0.01 | -0.02 | 0.01 | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | 462.61 Million | 444.23 Million | 410.9 Million | 326.13 Million | 223.03 Million | 195.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 462.59 Million | 444.23 Million | 410.9 Million | 391.4 Million | 223.03 Million | 195.4 Million |
| Gross Margin | - | 0.97 | - | - | - | - |
| EBIT Margin | - | -23.62 | - | - | - | - |
| Profit Margin | - | -22.98 | - | - | - | - |
| EBITDA | -4.01 Million | -3.78 Million | -6.19 Million | -2.69 Million | -1.8 Million | -2.72 Million |
| Earnings Before Tax Margin | - | -23.65 | - | - | - | - |
| Breakdown | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | 172 Thousand | - | - |
| Cost of Revenue | 3000.00 | 3000.00 | 3000.00 | 5000.00 | 2000.00 | 3000.00 |
| Gross Profit | -3000.00 | -3000.00 | -3000.00 | 167 Thousand | -2000.00 | -3000.00 |
| Operating Expenses | 1.64 Million | 2.64 Million | 1.62 Million | 4.06 Million | 2.43 Million | 6.19 Million |
| Selling, General and Administrative Expenses | 1.64 Million | 2.64 Million | 1.62 Million | - | 2.43 Million | - |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | - | - | - | 262 Thousand | - | 134 Thousand |
| Cost and Expenses | 1.64 Million | 2.64 Million | 1.63 Million | 4.06 Million | 2.43 Million | 6.19 Million |
| Operating Income | -1.64 Million | -2.64 Million | -1.63 Million | -4.06 Million | -2.43 Million | -6.19 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -3000.00 | -3000.00 | 351 Thousand | 319 Thousand | -32 Thousand | 223 Thousand |
| Earnings before Tax | -1.2 Million | -2.47 Million | -1.24 Million | -3.63 Million | -2.38 Million | -6.06 Million |
| Net Income | -1.2 Million | -2.47 Million | -1.6 Million | -3.95 Million | -2.35 Million | -6.28 Million |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.00 | - | -0.01 | - |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.00 | - | -0.01 | - |
| Weighted Average Shares Outstanding | 458.6 Million | 466.6 Million | 462.59 Million | 444.23 Million | 420.17 Million | 410.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 458.58 Million | 466.6 Million | 462.59 Million | 444.23 Million | 420.17 Million | 410.9 Million |
| Gross Margin | - | - | - | 0.97 | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | -22.98 | - | - |
| EBITDA | -1.37 Million | -2.64 Million | -1.62 Million | - | -2.43 Million | - |
| Earnings Before Tax Margin | - | - | - | -23.65 | - | - |
SURANAT&P
300965
CGVAK
MAU
CBSC
SELER